Axe Compute Inc. said it has engaged Cardiff Advisory LLC to help explore strategic alternatives for its Helomics business as it sharpens its focus on AI compute infrastructure. The board-supervised review may consider a sale, partnership, licensing arrangement, joint venture, or other transaction involving the Helomics biobank platform and related operations, with the goal of maximizing shareholder value from non-core legacy assets. The company said it may provide further updates only if its board approves a specific course of action or determines additional disclosure is appropriate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axe Compute Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602240800PRIMZONEFULLFEED9659929) on February 24, 2026, and is solely responsible for the information contained therein.